Afya (AFYA) Financials: History & Chart

Afya Limited(AFYA)

Education & Training Services · Belo Horizonte, MG

$13.31+1.09 (+8.92%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Afya Limited

Afya Limited, operating through its subsidiaries, is a prominent medical education provider in Brazil. The company delivers a comprehensive array of educational products and services primarily focused on the medical field, encompassing medical schools, preparatory courses for medical residency, advanced graduate studies, and various other programs tailored for medical professionals at all career stages. These offerings are available across its proprietary network and are also extended to external medical institutions. Beyond traditional education, Afya also offers digital health services through a subscription-based platform, accessible via a mobile app and website. This platform is specifically designed to assist healthcare practitioners and students with clinical decision-making by providing essential tools such as medical calculators, reference charts, up-to-date content, prescription guidance, clinical scoring systems, details on medical procedures, and laboratory examination information. While strong in medicine, Afya's educational portfolio spans a broader spectrum of health sciences, including dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine. Furthermore, the company extends its academic offerings beyond healthcare to include undergraduate and postgraduate degree programs in diverse subjects like business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. The company further enhances its educational ecosystem by providing specialized postgraduate medical programs, both printed and digital educational materials, an online medical learning platform, and hands-on medical training opportunities. As of December 31, 2021, Afya maintained an extensive network of 46 undergraduate and graduate medical school campuses, which included 30 operational undergraduate units and five approved units. This infrastructure supported a total capacity of 2,731 medical school seats, with 2,481 actively operating and an additional 278 seats approved for future use. Established in 1999, Afya Limited is headquartered in Nova Lima, Brazil.

Belo Horizonte, MG

9,395 employees

institucional.afya.com.br

Consumer Defensive / Education & Training Services

Sector: Consumer Defensive
Industry: Education & Training Services
CEO: Virgilio Deloy Capobianco Gibbon

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	725.74M	191.67M	191.00M	168.78M	174.28M	169.08M	163.86M	136.95M	154.02M
Cost of Goods Sold	261.22M	73.62M	59.34M	64.45M	63.80M	63.02M	49.46M	49.55M	59.34M
Gross Profit	464.52M	118.05M	131.66M	104.33M	110.48M	106.05M	114.40M	87.40M	94.68M
Gross Profit Margin	64.0%	61.6%	68.9%	61.8%	63.4%	62.7%	69.8%	63.8%	61.5%
Total Operating Expenses	230.37M	60.45M	57.62M	53.90M	58.40M	53.60M	49.21M	45.78M	51.86M
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	688K	N/A
Selling, General & Administrative	225.68M	60.45M	57.62M	53.90M	53.71M	53.86M	49.26M	45.99M	51.27M
Operating Income (EBIT)	234.15M	57.60M	74.04M	50.44M	52.07M	52.45M	65.19M	41.62M	42.83M
Operating Margin	32.3%	30.1%	38.8%	29.9%	29.9%	31.0%	39.8%	30.4%	27.8%
Income Before Tax (EBT)	169.17M	40.08M	57.38M	37.80M	33.91M	35.68M	49.32M	25.06M	25.01M
Interest Income	27.86M	7.46M	9.70M	N/A	10.70M	7.54M	2.54M	4.64M	-3.67M
Interest Expense	93.69M	24.10M	25.45M	21.36M	22.78M	24.97M	18.64M	18.91M	17.05M
Other Income/Expense	-64.98M	-17.52M	-16.66M	-12.63M	-18.17M	-16.77M	-15.87M	-16.56M	-17.82M
Net Income	148.44M	38.87M	48.47M	31.98M	29.12M	31.69M	44.10M	24.18M	21.97M
Income Tax Expense	17.75M	391K	8.01M	5.37M	3.98M	3.21M	4.34M	175K	2.28M
Net Profit Margin	20.5%	20.3%	25.4%	18.9%	16.7%	18.7%	26.9%	17.7%	14.3%
EBITDA	287.33M	75.46M	91.59M	50.44M	69.84M	69.87M	81.25M	49.61M	58.54M
EBITDA Margin	39.6%	39.4%	48.0%	29.9%	40.1%	41.3%	49.6%	36.2%	38.0%
Depreciation & Amortization	53.18M	17.86M	17.55M	0.00	17.77M	17.41M	16.06M	7.98M	15.72M
EPS Basic	1.65	0.44	0.55	0.35	0.32	0.35	0.49	0.27	0.24
EPS Diluted	1.64	0.44	0.54	0.35	0.32	0.35	0.48	0.27	0.24
Weighted Average Basic Shares	88.86M	88.86M	89.37M	90.31M	90.76M	90.70M	90.28M	90.77M	90.21M
Weighted Average Diluted Shares	89.30M	89.30M	90.13M	91.03M	91.32M	91.67M	97.25M	90.77M	91.28M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	660.04M	532.99M	591.58M	438.79M	307.94M	230.75M	186.53M	85.89M
Cost of Goods Sold	234.56M	196.08M	228.29M	161.94M	116.83M	83.50M	76.75M	43.22M
Gross Profit	425.48M	336.91M	363.29M	276.85M	191.11M	147.25M	109.78M	42.67M
Gross Profit Margin	64.5%	63.2%	61.4%	63.1%	62.1%	63.8%	58.9%	49.7%
Total Operating Expenses	208.90M	173.66M	205.50M	151.77M	112.15M	77.46M	58.78M	17.86M
Research & Development	N/A	3.24M	4.42M	1.78M	N/A	6K	N/A	N/A
Selling, General & Administrative	208.90M	172.19M	208.72M	150.37M	111.51M	77.39M	59.42M	18.01M
Operating Income (EBIT)	216.58M	163.25M	157.78M	125.12M	78.96M	69.80M	51.00M	24.81M
Operating Margin	32.8%	30.6%	26.7%	28.5%	25.6%	30.2%	27.3%	28.9%
Income Before Tax (EBT)	153.70M	109.10M	88.37M	80.72M	48.98M	64.36M	46.45M	25.39M
Interest Income	N/A	7.00M	22.03M	5.12M	4.13M	1.35M	2.25M	1.12M
Interest Expense	89.92M	59.09M	79.46M	54.38M	31.46M	3.13M	3.96M	618K
Other Income/Expense	-62.89M	-54.15M	-69.42M	-44.40M	-29.99M	-5.43M	-4.55M	585K
Net Income	134.33M	101.86M	79.47M	70.38M	40.00M	56.11M	38.25M	22.21M
Income Tax Expense	16.51M	4.43M	4.97M	6.72M	5.58M	5.20M	3.52M	1.03M
Net Profit Margin	20.4%	19.1%	13.4%	16.0%	13.0%	24.3%	20.5%	25.9%
EBITDA	216.58M	196.18M	217.34M	165.05M	106.59M	90.83M	69.18M	27.28M
EBITDA Margin	32.8%	36.8%	36.7%	37.6%	34.6%	39.4%	37.1%	31.8%
Depreciation & Amortization	0.00	32.92M	59.55M	39.93M	27.62M	21.04M	18.18M	2.48M
EPS Basic	1.49	1.13	0.88	0.78	0.43	0.61	0.50	0.25
EPS Diluted	1.48	1.12	0.88	0.78	0.42	0.60	0.50	0.25
Weighted Average Basic Shares	90.48M	90.12M	90.47M	89.94M	93.29M	92.68M	75.97M	87.68M
Weighted Average Diluted Shares	91.27M	91.15M	90.54M	89.94M	94.10M	93.64M	76.19M	87.68M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.